Showing 1 - 8 results of 8 for search 'D. A. Kusevich', query time: 0.02s Refine Results
  1. 1
    THE ROLE OF LABORATORY BIOMARKERS IN PREDICTING THE EFFICIENCY OF RITUXIMAB THERAPY FOR RHEUMATOID ARTHRITIS: NEW EVIDENCE

    THE ROLE OF LABORATORY BIOMARKERS IN PREDICTING THE EFFICIENCY OF RITUXIMAB THERAPY FOR RHEUMATOID ARTHRITIS: NEW EVIDENCE by A. S. Avdeeva, D. A. Kusevich

    Published 2017-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    THE EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS: NEW EVIDENCE

    THE EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS: NEW EVIDENCE by D. A. Kusevich, A. S. Avdeeva

    Published 2017-09-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Comparison of the efficacy and safety of the original rituximab and its biosimilar in routine clinical practice

    Comparison of the efficacy and safety of the original rituximab and its biosimilar in routine clinical practice by D. A. Kusevich, Yu. A. Olyunin, E. L. Nasonov

    Published 2022-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Severe rheumatoid arthritis with multiple baseline anti-inflammatory drugs intolerance

    Severe rheumatoid arthritis with multiple baseline anti-inflammatory drugs intolerance by D. A. Kusevich, G. R. Imametdinova, N. V. Chichasova, E. L. Nasonov

    Published 2016-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    IMMUNOLOGICAL EFFECTS OF A RITUXIMAB BIOSIMILAR (ACELBIA, BIOCAD) IN PATIENTS WITH RHEUMATOID ARTHRITIS

    IMMUNOLOGICAL EFFECTS OF A RITUXIMAB BIOSIMILAR (ACELBIA, BIOCAD) IN PATIENTS WITH RHEUMATOID ARTHRITIS by A. S. Avdeeva, M. V. Cherkasova, D. A. Kusevich, V. V. Rybakova, E. L. Nasonov

    Published 2018-11-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice

    Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice by D. A. Kusevich, A. S. Avdeeva, V. V. Rybakova, N. V. Chichasova, E. L. Nasonov

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Evaluation of rituximab therapy in real clinical practice (according to the OREL registry of patients with rheumatoid arthritis

    Evaluation of rituximab therapy in real clinical practice (according to the OREL registry of patients with rheumatoid arthritis by A. S. Avdeeva, A. M. Satybaldyev, N. V. Demidova, N. Yu. Nikishina, E. V. Gerasimova, N. V. Muravyeva, G. I. Gridneva, O. A. Rumyantseva, K. A. Kasumova, A. V. Alekseeva, N. V. Chichasova, D. A. Kusevich, V. V. Rybakova, E. A. Koshkarova, A. M. Lila, E. L. Nasonov

    Published 2019-07-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III

    Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III by E. V. Akatova, Yu. S. Bakhareva, O. V. Bugrova, I. B. Vinogradova, E. V. Gerasimova, Yu. E. Drevina, O. B. Ershova, E. V. Zonova, Yu. I. Ivanova, E. P. Ilivanova, M. M. Kostik, D. G. Krechikova, D. A. Kusevich, A. L. Maslyansky, A. D. Meshkov, N. S. Mosesova, K. A. Nagornova, D. V. Nosovich, S. A. Polyakova, T. A. Popova, E. A. Smolyarchuk, V. N. Sorotskaya, Yu. G. Shvarts, L. N. Shilova, M. S. Shostak, I. Yu. Yunonin, N. E. Akhtyamova-Givirovskaya, R. A. Khamitov, O. A. Markova, E. I. Zagoruiko, E. V. Zuev

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: